“7. If any further proceedings are commenced by or on behalf of any of the individuals or entities identified in the first column of the schedule hereto (titled “Claimants/Applicants”) against any one or more of the individuals or entities identified in the second column of the schedule hereto (titled “Defendants/Respondents”) the individual who has purported to sign the statement of truth on the claim form on behalf of the named Claimants shall at the same time as filing the claim form also file at court (and serve on each Defendant in the manner specified in paragraphs 2 and 5 above) evidence given by way of witness statement attesting to his or her identity. Where evidence of the kind specified above is not duly filed and served or is considered by a Defendant to be inadequate, that Defendant may apply with an application to be determined by Mr Justice Miles, if possible, for the proceedings to be struck out.”
“19. Since at least1 April 2021 , and at all material times thereafter, the Claimants were and are Ultimate Account Holders, and collectively: (a) held and hold a controlling (representing in aggregate, over 50% of the Principal Outstanding Amount of the Notes) ultimate beneficial (or equitable) interest in the Notes issued by the Issuers and, as such, have absolute and uncontrolled discretion and control as to the exercise or non-exercise of all the rights (including, voting rights) attaching to the Issuers held by the Instrumentholder; fixed by reference to the face value of the Notes comprising of their controlling ultimate beneficial interests; and (b) were and are accordingly contingent creditors in light of their entitlement subject to the fulfilment or satisfaction of one or more of the conditions and circumstances related to the issuance of Definitive Notes and as stipulated in Condition 13 of the Notes Terms and Conditions - to an equivalent number of Notes (and thereof to be treated as their absolute owner for all purposes). 20. Customer evidence in the standard form is provided [RD1.2.30]. 21. On or around10 July 2020 , the Defendant forfeited 49,998 partly paid (25% paid) shares in each Issuer to Highbury Investments Limited (“Highbury”) for a total price of approx.£20 million . 22. Whilst it is or may be alleged by certain parties that the forfeiture is invalid, I note the following in each Issuer’s articles of association “the “Articles”): (a) Articles 13(B) in respect of the Issuer’s first and paramount lien on all partly paid shares: “…the title of the transferee is not affected by an irregularity in or invalidity of the proceedings connected with the sale” [RD1.74]; and (b) Articles 23(C) in respect of a disposal of forfeited shares: “…the person to whom the share is sold, re-allotted or disposed of is not bound to see to the application of the consideration (if any). His title to the share is not affected by an irregularity in or invalidity of the proceedings connected with the forfeiture or disposal” [RD1.75]. 23. The wording and construction of the Articles of each Issuer is fairly standard. The relevant wording is also replicated in the wider market and used, for example, in the model articles. 24. The Defendant retains, and has done so at all material times, 1 fully-paid share in each Issuer. 25. The Defendant holds on trust the voting rights attached to the ordinary shares it holds in each Issuer on trust for the benefit and protection of the Ultimate Account Holders of each respective Issuer. 26. On: (a)28 August 2020 , Highbury sold 15,000, 10,000 and 7,500 shares in BMF4 to the Third, First and Second Claimant, respectively, for a price of£132 per share [RD1.31-33]; (b)04 September 2020 , Highbury sold 15,000, 10,000 and 7,500 shares in BMF5 to the Third, First and Second Claimant, respectively, for a price of£83 per share [RD1.34-36]; (c)04 September 2020 , Highbury sold 15,000, 10,000 and 7,500 shares in BMF6 to the Third, First and Second Claimant, respectively, for a price of£107 per share [RD1.37-79]; and (d)28 August 2020 , Highbury sold 15,000, 10,000 and 7,500 shares in BMF7 to the Third, First and Second Claimant, respectively, for a price of£82 per share [RD1.40-42]. 27. The Claimants retain the aforementioned shares, and, as such, collectively, hold 32,500 shares (out of a total of£50,000 ) in each Issuer, representing 65% of the total share capital and, consequently, the majority of the voting rights as members of each Issuer. 28. The Claimants (just like the Defendant) hold on trust the voting rights attached to the ordinary shares they hold in each Issuer on trust for the benefit and protection of the Ultimate Account Holders of each respective Issuer. The Extraordinary General Meeting held on27 January 2022 29. On19 November 2021 , in their capacity as shareholders and members, the Claimants served the Board of directors of each Issuer with a notice (in accordance with theCompanies Act 1985 and all statutes and subordinary legislation made thereunder for the lime being in force concerning the Issuers and affecting the Issuers, the “Acts”) requisitioning an extraordinary general meeting (the “EGM”) for each Issuer to be held on27 January 2022 between 10.00am - 11.00am (GMT) (the “Members Notice”). The Extraordinary General Meeting held on27 January 2022 30. The purpose of the EGM’s was to consider and if thought fit pass ordinary resolutions (without prejudice to any prior removal, resignation, appointment or assumption): (i) removing the Nominee Directors as directors of each Issuer with immediate effect, and (ii) ratifying, confirming, and appointing the Additional Directors as de jure directors of each Issuer, with immediate effect, and the approval, ratification, and confirmation, to the fullest extent possible, of all actions taken in their capacity or purported capacity thereof. 31. The Members Notice, amongst other things, reminded the Board of directors of each Issuer of their obligations and duties, under the Acts and the Articles of each Issuer, to call the EGM for each Issuer and to do so within a necessary timeframe. 32. However, no response was proffered and the EGM was not called within the necessary timeframe, in default of the Acts, as well as the Articles of each Issuer. 33. Therefore, after the failure, the Claimants called the EGM for each Issuer for the same dates and times. 34. The EGM’s for each Issuer were duly convened and held on27 January 2022 between 10.00am - 11.00am (GMT), with a necessary quorum of members present, and all resolutions were unanimously carried and passed [RD1.63-66]. 35. Notice of the results of the EGM were served shortly after upon the Nominee Directors [RD1.67-69]. The 28 January Direction 36. On28 January 2022 , the Claimants in their capacity as controlling Ultimate Account Holders served the 28 January Direction on the Defendant RD1.70-73]. 37. At the time of writing, it is not clear if the Defendant has complied or is willing to comply with the 28 January Direction.”
“The Defendant holds on trust the voting rights attached to the ordinary shares it holds in each Issuer on trust for the benefit and protection of the Ultimate Account Holders of each perspective Issuer.”
“Since the Defendants were never validly or effectively appointed as directors of the Issuers, none of the notices of unpaid members' calls, share forfeitures or the purported sale of the Issuers' shares to Highbury can have been valid or effective either. The last of these steps, the sale to Highbury, was carried out by the Defendants as purported directors. But because the purported call and forfeiture were invalid the shares remained in the ownership of BMFH. The Issuers (for whom the Defendants purported to act) had no property in the shares and therefore had nothing to sell to Highbury. Any purported sale was therefore a nullity.”